Published in Gastroenterology on August 01, 2006
Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut (2012) 2.60
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol (2010) 2.23
Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol (2009) 2.02
Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol (2011) 1.89
Global Epidemiology of Campylobacter Infection. Clin Microbiol Rev (2015) 1.73
Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS One (2012) 1.63
Brain-gut-microbe communication in health and disease. Front Physiol (2011) 1.59
Development of functional gastrointestinal disorders after Giardia lamblia infection. BMC Gastroenterol (2009) 1.48
Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend Med (2009) 1.28
Campylobacter jejuni induces transcellular translocation of commensal bacteria via lipid rafts. Gut Pathog (2009) 1.24
Irritable bowel syndrome, gut microbiota and probiotics. J Neurogastroenterol Motil (2011) 1.23
Irritable bowel syndrome: methods, mechanisms, and pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2012) 1.19
Recreational water-related illness: office management and prevention. Can Fam Physician (2013) 1.19
The immune system in irritable bowel syndrome. J Neurogastroenterol Motil (2011) 1.16
Post-infectious irritable bowel syndrome. World J Gastroenterol (2009) 1.15
Irritable bowel syndrome: a clinical review. World J Gastroenterol (2014) 1.10
The gut microbiota and irritable bowel syndrome: friend or foe? Int J Inflam (2012) 1.09
Campylobacter polysaccharide capsules: virulence and vaccines. Front Cell Infect Microbiol (2012) 1.08
An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil (2012) 1.07
Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol (2014) 1.06
Campylobacter jejuni drives MyD88-independent interleukin-6 secretion via Toll-like receptor 2. Infect Immun (2009) 1.04
Comparison of methods for detection of Blastocystis infection in routinely submitted stool samples, and also in IBS/IBD Patients in Ankara, Turkey. PLoS One (2010) 1.03
Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol (2012) 0.97
A gastroenterologist's guide to probiotics. Clin Gastroenterol Hepatol (2012) 0.96
Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases. Epidemiol Infect (2007) 0.96
Carbohydrate malabsorption in patients with non-specific abdominal complaints. World J Gastroenterol (2007) 0.92
The Influence of the Gut Microbiome on Obesity, Metabolic Syndrome and Gastrointestinal Disease. Clin Transl Gastroenterol (2015) 0.92
Irritable bowel syndrome: the role of food in pathogenesis and management. Gastroenterol Hepatol (N Y) (2014) 0.91
Severity of Giardia infection associated with post-infectious fatigue and abdominal symptoms two years after. BMC Infect Dis (2009) 0.90
Antagonistic activity of Lactobacillus acidophilus ATCC 4356 on the growth and adhesion/invasion characteristics of human Campylobacter jejuni. Curr Microbiol (2012) 0.88
Microbiological quality of drinking water from dispensers in Italy. BMC Microbiol (2010) 0.88
Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome. PLoS One (2014) 0.87
Irritable bowel syndrome. BMJ Clin Evid (2012) 0.87
The duration of gastrointestinal and joint symptoms after a large waterborne outbreak of gastroenteritis in Finland in 2007--a questionnaire-based 15-month follow-up study. PLoS One (2014) 0.86
Convergence of neuro-endocrine-immune pathways in the pathophysiology of irritable bowel syndrome. World J Gastroenterol (2014) 0.85
Irritable bowel syndrome and chronic fatigue 6 years after giardia infection: a controlled prospective cohort study. Clin Infect Dis (2014) 0.85
New horizons for the infectious diseases specialist: how gut microflora promote health and disease. Curr Infect Dis Rep (2008) 0.85
Overlap of functional dyspepsia and GERD--diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol (2013) 0.84
Genes and environment in irritable bowel syndrome: one step forward. Gut (2006) 0.84
Infectious causation of chronic disease: examining the relationship between Giardia lamblia infection and irritable bowel syndrome. World J Gastroenterol (2007) 0.83
Citrobacter rodentium colitis evokes post-infectious hyperexcitability of mouse nociceptive colonic dorsal root ganglion neurons. J Physiol (2009) 0.83
Campylobacter jejuni and Campylobacter coli in children from communities in Northeastern Brazil: molecular detection and relation to nutritional status. Diagn Microbiol Infect Dis (2010) 0.83
The effects of gut microbiota on CNS function in humans. Gut Microbes (2014) 0.83
Targeted therapies for diarrhea-predominant irritable bowel syndrome. Clin Exp Gastroenterol (2012) 0.82
All Roads Lead to Rome: Update on Rome III Criteria and New Treatment Options. Gastroenterol Rep (2007) 0.82
Giardia duodenalis induces paracellular bacterial translocation and causes postinfectious visceral hypersensitivity. Am J Physiol Gastrointest Liver Physiol (2016) 0.82
Low risk of irritable bowel syndrome after Clostridium difficile infection. Can J Gastroenterol (2007) 0.82
Role of gut pathogens in development of irritable bowel syndrome. Indian J Med Res (2014) 0.81
Probiotic products in Canada with clinical evidence: what can gastroenterologists recommend? Can J Gastroenterol (2008) 0.81
Effect of probiotics on gastrointestinal function: evidence from animal models. Therap Adv Gastroenterol (2009) 0.80
Pharmacology of inflammatory pain: local alteration in receptors and mediators. Dig Dis (2010) 0.80
High risk of post-infectious irritable bowel syndrome in patients with Clostridium difficile infection. Aliment Pharmacol Ther (2016) 0.80
Canadian Digestive Health Foundation Public Impact Series 3: irritable bowel syndrome in Canada. Incidence, prevalence, and direct and indirect economic impact. Can J Gastroenterol (2012) 0.79
Motility response to colonic distention is increased in postinfectious irritable bowel syndrome (PI-IBS). Neurogastroenterol Motil (2014) 0.79
Intraluminal administration of poly I:C causes an enteropathy that is exacerbated by administration of oral dietary antigen. PLoS One (2014) 0.79
Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case report. BMC Res Notes (2013) 0.78
Do probiotics improve symptoms in patients with irritable bowel syndrome? Therap Adv Gastroenterol (2009) 0.78
Soluble mediators released from PI-IBS patients' colon induced alteration of mast cell: involvement of reactive oxygen species. Dig Dis Sci (2011) 0.78
Campylobacter jejuni Increases Flagellar Expression and Adhesion of Noninvasive Escherichia coli: Effects on Enterocytic Toll-Like Receptor 4 and CXCL-8 Expression. Infect Immun (2015) 0.78
Advances in IBS 2016: A Review of Current and Emerging Data. Gastroenterol Hepatol (N Y) (2016) 0.78
Irritable bowel syndrome. BMJ Clin Evid (2010) 0.77
Postinfectious functional gastrointestinal disorders: a focus on epidemiology and research agendas. Gastroenterol Hepatol (N Y) (2013) 0.77
The psyche and the gut. World J Gastroenterol (2007) 0.77
Long-term health risks for children and young adults after infective gastroenteritis. Emerg Infect Dis (2010) 0.77
Management Strategies for Abdominal Bloating and Distension. Gastroenterol Hepatol (N Y) (2014) 0.76
Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104:H4: A cohort study with prospective follow-up. United European Gastroenterol J (2015) 0.76
Prevalence, Risk Factors, and Outcomes of Irritable Bowel Syndrome After Infectious Enteritis: a Systematic Review and Meta-analysis. Gastroenterology (2017) 0.76
Do Patients with Functional Gastrointestinal Disorders have an Altered Gut Flora? Therap Adv Gastroenterol (2009) 0.76
A controlled survey of less typical long-term consequences after an extensive waterborne epidemic. BMC Infect Dis (2017) 0.75
Use of rifaximin in gastrointestinal and liver diseases. World J Gastroenterol (2016) 0.75
The irritable infection. Interview by Paul C Adams. Can J Gastroenterol (2008) 0.75
Role of environmental pollution in irritable bowel syndrome. World J Gastroenterol (2015) 0.75
Long-term Prognosis of Postinfectious Irritable Bowel Syndrome (Gut 2010;59:605-611). J Neurogastroenterol Motil (2010) 0.75
The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol (2017) 0.75
Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link. Nat Rev Gastroenterol Hepatol (2017) 0.75
Post-Infectious Irritable Bowel Syndrome. Curr Gastroenterol Rep (2017) 0.75
Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome. Gastroenterology (2017) 0.75
Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA (2002) 8.30
A tutorial on pilot studies: the what, why and how. BMC Med Res Methodol (2010) 7.47
Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.54
Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol (2006) 6.21
Aspirin in patients undergoing noncardiac surgery. N Engl J Med (2014) 6.10
Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology (2013) 5.69
Comparison of mortality between private for-profit and private not-for-profit hemodialysis centers: a systematic review and meta-analysis. JAMA (2002) 5.57
Age affects outcomes in chronic kidney disease. J Am Soc Nephrol (2007) 5.36
Helping patients follow prescribed treatment: clinical applications. JAMA (2002) 5.18
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03
Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58
Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol (2002) 4.52
Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Intern Med (2013) 4.35
Meta-analysis: risk for hypertension in living kidney donors. Ann Intern Med (2006) 4.32
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology (2004) 4.05
Early start of hemodialysis may be harmful. Arch Intern Med (2010) 3.83
Global trends in the rates of living kidney donation. Kidney Int (2009) 3.81
When laboratories report estimated glomerular filtration rates in addition to serum creatinines, nephrology consults increase. Kidney Int (2009) 3.70
Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol (2011) 3.53
A multinational cohort study of in-center daily hemodialysis and patient survival. Kidney Int (2012) 3.47
Initiation of dialysis at higher GFRs: is the apparent rising tide of early dialysis harmful or helpful? Kidney Int (2009) 3.36
Genetic risk factors for post-infectious irritable bowel syndrome following a waterborne outbreak of gastroenteritis. Gastroenterology (2010) 3.32
The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study*. Crit Care Med (2014) 3.29
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology (2011) 3.29
Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression. JAMA (2003) 2.97
Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med (2010) 2.97
Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study. Ann Intern Med (2014) 2.93
Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int (2002) 2.92
Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol (2011) 2.90
The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology (2011) 2.71
Plasma exchange when myeloma presents as acute renal failure: a randomized, controlled trial. Ann Intern Med (2005) 2.67
Complications of daytime elective laparoscopic cholecystectomies performed by surgeons who operated the night before. JAMA (2013) 2.63
An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol (2004) 2.58
Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ (2013) 2.58
Nephrologist follow-up improves all-cause mortality of severe acute kidney injury survivors. Kidney Int (2013) 2.42
The direct and indirect economic costs incurred by living kidney donors-a systematic review. Nephrol Dial Transplant (2006) 2.41
Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int (2002) 2.32
Global trends in rates of peritoneal dialysis. J Am Soc Nephrol (2012) 2.29
Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. JAMA (2006) 2.22
Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut (2010) 2.21
Trimethoprim-sulfamethoxazole induced hyperkalaemia in elderly patients receiving spironolactone: nested case-control study. BMJ (2011) 2.20
Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol (2012) 2.15
Statin use associates with a lower incidence of acute kidney injury after major elective surgery. J Am Soc Nephrol (2011) 2.11
Shift work and vascular events: systematic review and meta-analysis. BMJ (2012) 2.10
The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis. Am J Gastroenterol (2006) 2.09
Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol (2011) 2.07
Clonidine in patients undergoing noncardiac surgery. N Engl J Med (2014) 2.07
Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology (2002) 2.02
Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol (2012) 2.00
Daily hemodialysis: a systematic review. Clin J Am Soc Nephrol (2005) 1.97
Living kidney donors requiring transplantation: focus on African Americans. Transplantation (2007) 1.92
New fibrate use and acute renal outcomes in elderly adults: a population-based study. Ann Intern Med (2012) 1.91
Dipstick proteinuria as a screening strategy to identify rapid renal decline. J Am Soc Nephrol (2011) 1.91
Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Kidney Int (2011) 1.88
Survival with three-times weekly in-center nocturnal versus conventional hemodialysis. J Am Soc Nephrol (2012) 1.88
Preoperative statin use and postoperative acute kidney injury. Am J Med (2012) 1.87
Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. Gastroenterology (2005) 1.86
Chronic gastrointestinal inflammation induces anxiety-like behavior and alters central nervous system biochemistry in mice. Gastroenterology (2010) 1.85
Burden on caregivers as perceived by hemodialysis patients in the Frequent Hemodialysis Network (FHN) trials. Nephrol Dial Transplant (2011) 1.85
Early dialysis initiation and rates and timing of withdrawal from dialysis in Canada. Clin J Am Soc Nephrol (2012) 1.80
The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology (2006) 1.75
Marked variation in the definition and diagnosis of delayed graft function: a systematic review. Nephrol Dial Transplant (2008) 1.74
Validity of administrative database coding for kidney disease: a systematic review. Am J Kidney Dis (2011) 1.73
Role of IL-4, IL-13, and STAT6 in inflammation-induced hypercontractility of murine smooth muscle cells. Am J Physiol Gastrointest Liver Physiol (2002) 1.72
Computerized clinical decision support systems for chronic disease management: a decision-maker-researcher partnership systematic review. Implement Sci (2011) 1.70
The secret of immortal time bias in epidemiologic studies. J Am Soc Nephrol (2008) 1.68
The prognostic importance of a small acute decrement in kidney function in hospitalized patients: a systematic review and meta-analysis. Am J Kidney Dis (2007) 1.66
Informing the debate: rates of kidney transplantation in nations with presumed consent. Ann Intern Med (2010) 1.65
Impaired renal function modifies the risk of severe hypoglycaemia among users of insulin but not glyburide: a population-based nested case-control study. Nephrol Dial Transplant (2010) 1.65
Oral bisphosphonate use in the elderly is not associated with acute kidney injury. Kidney Int (2012) 1.64
The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods. BMC Nephrol (2010) 1.63
A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Med Res Methodol (2013) 1.63
Acute dialysis risk in living kidney donors. Nephrol Dial Transplant (2012) 1.60
Pregnancy outcomes in women with chronic kidney disease: a systematic review. Clin J Am Soc Nephrol (2011) 1.59
Prevalence of uninvestigated dyspepsia 8 years after a large waterborne outbreak of bacterial dysentery: a cohort study. Gastroenterology (2010) 1.58
Regional effects of satellite haemodialysis units on renal replacement therapy in non-urban Ontario, Canada. Nephrol Dial Transplant (2007) 1.58
A nurse-coordinated model of care versus usual care for stage 3/4 chronic kidney disease in the community: a randomized controlled trial. Clin J Am Soc Nephrol (2011) 1.58
Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change. Clin J Am Soc Nephrol (2006) 1.58
Diabetes during diarrhea-associated hemolytic uremic syndrome: a systematic review and meta-analysis. Diabetes Care (2005) 1.53
Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. Gastroenterology (2002) 1.50
Effect of awareness of a randomized controlled trial on use of experimental therapy. JAMA (2003) 1.50
Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol (2013) 1.48
Canadian Society of Nephrology 2014 clinical practice guideline for timing the initiation of chronic dialysis. CMAJ (2014) 1.48